We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Speculation builds over Pfizer return

    31 October 2014

    Pfizer chief execuitve Ian Read has come to the defence of tax inversion deals, prompting speculation it will reapproach AstraZeneca.

Register today and get...

Register today and get...
Please note terms & conditions apply